Dai Ichi Life Insurance Company, LTD Gilead Sciences, Inc. Transaction History

Dai Ichi Life Insurance Company, LTD

  • $3.9 Billion
  • Q3 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 171,416 shares of GILD stock, worth $15.7 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
171,416
Previous 377,017 54.53%
Holding current value
$15.7 Million
Previous $25.9 Million 44.45%
% of portfolio
0.37%
Previous 0.64%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $13.7 Million - $17.3 Million
-205,601 Reduced 54.53%
171,416 $14.4 Million
Q2 2024

Aug 08, 2024
BUY
$63.15 - $72.88 $7.1 Million - $8.19 Million
112,395 Added 42.47%
377,017 $25.9 Million
Q1 2024

May 09, 2024
SELL
$71.58 - $87.29 $4.63 Million - $5.64 Million
-64,661 Reduced 19.64%
264,622 $19.4 Million
Q4 2023

Feb 09, 2024
SELL
$73.27 - $83.09 $31.6 Million - $35.8 Million
-431,436 Reduced 56.71%
329,283 $26.7 Million
Q3 2023

Nov 02, 2023
BUY
$73.94 - $80.67 $29.9 Million - $32.6 Million
404,000 Added 113.25%
760,719 $57 Million
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $670,788 - $765,127
8,825 Added 2.54%
356,719 $27.5 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $2.93 Million - $3.34 Million
37,911 Added 12.23%
347,894 $28.9 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $2.02 Million - $2.9 Million
-32,383 Reduced 9.46%
309,983 $26.6 Million
Q2 2022

Aug 12, 2022
SELL
$57.72 - $65.01 $7.41 Million - $8.34 Million
-128,337 Reduced 27.26%
342,366 $21.2 Million
Q1 2022

May 13, 2022
SELL
$57.92 - $72.58 $3.61 Million - $4.52 Million
-62,339 Reduced 11.69%
470,703 $28 Million
Q4 2021

Feb 11, 2022
SELL
$64.88 - $73.64 $172,256 - $195,514
-2,655 Reduced 0.5%
533,042 $38.7 Million
Q3 2021

Nov 04, 2021
SELL
$67.69 - $73.03 $5.51 Million - $5.95 Million
-81,434 Reduced 13.2%
535,697 $37.4 Million
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $8.17 Million - $8.92 Million
128,672 Added 26.34%
617,131 $42.5 Million
Q1 2021

May 13, 2021
SELL
$60.0 - $68.46 $1.74 Million - $1.98 Million
-28,960 Reduced 5.6%
488,459 $31.6 Million
Q4 2020

Feb 11, 2021
BUY
$56.65 - $64.55 $11.1 Million - $12.6 Million
195,237 Added 60.6%
517,419 $30.1 Million
Q3 2020

Nov 12, 2020
BUY
$62.1 - $78.08 $3.26 Million - $4.1 Million
52,535 Added 19.48%
322,182 $20.4 Million
Q2 2020

Aug 12, 2020
BUY
$72.34 - $84.0 $8.8 Million - $10.2 Million
121,583 Added 82.12%
269,647 $20.7 Million
Q1 2020

May 08, 2020
BUY
$62.63 - $80.22 $3.09 Million - $3.95 Million
49,286 Added 49.9%
148,064 $11.1 Million
Q4 2019

Feb 13, 2020
SELL
$61.62 - $67.78 $2.13 Million - $2.35 Million
-34,632 Reduced 25.96%
98,778 $6.42 Million
Q3 2019

Nov 13, 2019
SELL
$62.51 - $69.0 $191,280 - $211,140
-3,060 Reduced 2.24%
133,410 $8.46 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $28,645 - $32,122
-463 Reduced 0.34%
136,470 $9.22 Million
Q1 2019

May 14, 2019
SELL
$62.53 - $70.05 $54,338 - $60,873
-869 Reduced 0.63%
136,933 $8.9 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $70,165 - $91,561
-1,159 Reduced 0.83%
137,802 $8.62 Million
Q3 2018

Nov 13, 2018
SELL
$71.28 - $78.92 $962,493 - $1.07 Million
-13,503 Reduced 8.86%
138,961 $10.7 Million
Q2 2018

Aug 10, 2018
SELL
$64.88 - $75.68 $1.08 Million - $1.26 Million
-16,618 Reduced 9.83%
152,464 $10.8 Million
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $911,519 - $1.11 Million
12,514 Added 7.99%
169,082 $12.7 Million
Q4 2017

Feb 13, 2018
SELL
$71.15 - $83.52 $272,717 - $320,132
-3,833 Reduced 2.39%
156,568 $11.2 Million
Q3 2017

Nov 09, 2017
BUY
$72.11 - $85.47 $11.6 Million - $13.7 Million
160,401
160,401 $13 Million

Others Institutions Holding GILD

# of Institutions
1,941
Shares Held
989M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email